Sun Pharmaceutical Gets FDA Approval for Epinastine Eye Drops

Sun Pharmaceutical Industries Ltd. (SUNP), India’s biggest drugmaker by market value, received approval from the U.S. Food and Drug Administration for its epinastine hydrochloride eye drops, the generic version of Allergan Inc.’s Elestat anti-allergy medicine, according to a statement on the FDA website.

To contact the reporter on this story: Adi Narayan in Mumbai at anarayan8@bloomberg.net

To contact the editor responsible for this story: Niveditha Ravi at nravi2@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.